STAAR Surgical Co Cash and Restricted Cash
STAAR Surgical Co (STAA) had Cash and Restricted Cash of $148.58 million as of 2026-07-03, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-07-03: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $148.58M.
- 2026-04-03: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $131.86M.
- 2026-01-02: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $153.15M.
- 2025-09-26: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $176.16M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-07-03 | $148.58M 10-Q · filed 2026-08-12 |
| 2026-04-03 | $131.86M 10-Q · filed 2026-05-13 |
| 2026-01-02 | $153.15M 10-Q · filed 2026-08-12 |
| 2025-09-26 | $176.16M 10-Q · filed 2025-11-05 |
| 2025-06-27 | $167.13M 10-Q · filed 2026-08-12 |
| 2025-03-28 | $173.11M 10-Q · filed 2026-05-13 |
| 2024-12-27 | $144.16M 10-Q · filed 2026-08-12 |
| 2024-09-27 | $164.00M 10-Q · filed 2025-11-05 |
| 2024-06-28 | $192.78M 10-Q · filed 2025-08-06 |
| 2024-03-29 | $224.02M 10-Q · filed 2025-05-07 |
| 2023-12-29 | $183.04M 10-K · filed 2026-03-03 |
| 2023-09-29 | $127.43M 10-Q · filed 2024-10-30 |
| 2023-06-30 | $94.69M 10-Q · filed 2024-08-07 |
| 2023-03-31 | $89.97M 10-Q · filed 2024-05-07 |
| 2022-12-30 | $86.48M 10-K · filed 2026-03-03 |
| 2022-09-30 | $129.24M 10-Q · filed 2023-11-06 |
| 2022-07-01 | $202.49M 10-Q · filed 2023-08-02 |
| 2022-04-01 | $193.07M 10-Q · filed 2023-05-03 |
| 2021-12-31 | $199.71M 10-K · filed 2025-02-21 |
| 2021-10-01 | $196.25M 10-Q · filed 2022-11-02 |
| 2021-07-02 | $173.08M 10-Q · filed 2022-08-10 |
| 2021-04-02 | $162.34M 10-Q · filed 2022-05-04 |
| 2021-01-01 | $152.45M 10-K · filed 2024-02-27 |
| 2020-10-02 | $128.34M 10-Q · filed 2021-11-03 |
| 2020-07-03 | $116.31M 10-Q · filed 2021-08-04 |
| 2020-04-03 | $110.85M 10-Q · filed 2021-05-05 |
| 2020-01-03 | $119.97M 10-K · filed 2023-02-23 |
| 2019-09-27 | $112.33M 10-Q · filed 2020-11-04 |
| 2019-06-28 | $103.25M 10-Q · filed 2020-08-05 |
| 2019-03-29 | $102.23M 10-Q · filed 2020-05-06 |
| 2018-12-28 | $104.00M 10-K · filed 2022-02-23 |
| 2018-09-28 | $102.32M 10-Q · filed 2019-10-30 |
| 2018-06-29 | $21.37M 10-Q · filed 2019-07-31 |
| 2018-03-30 | $20.89M 10-Q · filed 2019-05-01 |
| 2017-12-29 | $18.64M 10-K · filed 2021-02-24 |
| 2017-09-29 | $16.25M 10-Q · filed 2018-10-31 |
| 2017-06-30 | $13.56M 10-Q · filed 2018-08-01 |
| 2017-03-31 | $13.62M 10-Q · filed 2018-05-02 |
| 2016-12-31 | $14.12M 10-Q · filed 2018-05-02 |
| 2016-12-30 | $14.12M 10-K · filed 2020-02-26 |
| 2016-12-29 | $14.12M 10-Q · filed 2018-10-31 |
| 2016-09-30 | $14.40M 10-Q · filed 2017-11-08 |
| 2016-01-01 | $13.52M 10-K · filed 2019-02-21 |
| 2015-01-02 | $13.13M 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |